While 177Lu-PSMA-617 has improved survival, many patients eventually see their cancer progress as the disease develops resistance to beta-particle radiation. This clinical hurdle has forced researchers to look beyond standard therapies toward the high-energy potential of alpha-emitting isotopes.
Leptomeningeal disease represents a particular diagnostic challenge where cancer spreads to the protective membranes and fluid surrounding the brain. This condition often presents a clinical puzzle, as the traditional tools used to visualize the central nervous system frequently struggle to provide
Patients receiving Roche’s divarasib lived a median of roughly 18 months in a Phase 3 lung cancer trial, compared with about 12 months among those receiving Krazati or Lumakras. That finding, presented at the European Society for Medical Oncology meeting, sits alongside encouraging results for a
Researchers analyzing the DNA of UK Biobank participants found 60 independent genetic variants associated with liver triglyceride levels. This monumental effort, which utilized magnetic resonance imaging data from a cohort of 71,488 individuals of European descent, has fundamentally altered the
The development of B-SYNC is an evolution of the 2021 E-SYNC model, moving from a rare mutant protein trigger to a more universal brain protein to help a broader range of patients. In the current landscape of pediatric medicine, few diagnoses carry as much weight as diffuse midline glioma, an
Advanced deep learning has reached a pivotal moment in medical imaging with the introduction of a dual-branch architecture that identifies brain tumors with exceptional precision. As of 2026, the medical community continues to face an overwhelming surge in diagnostic imaging data, placing an